Obesity / Blood draw / Lifestyle tools for weight loss · Interventional Study

Feasibility Study for the Comprehensive Overweight/Obesity Management Pre-Kidney Transplant (COMPKT) Program

ClinicalTrials.gov · August 11, 2026

Preliminary Why this matters to you Expert discussion

Early or partial results. Treat as a signal, not a conclusion.

AI Summary

This is a completed single-arm feasibility study registered at ClinicalTrials.gov examining a behavioral and technological weight loss intervention in kidney transplant candidates. No efficacy or safety results are reported in this registry record; the study documents only the intervention protocol and planned outcome measures.

What was studied

Interventional, Single Group, Open label, Treatment purpose. Kidney Transplant; Complications, Obesity; age from 18 Years. Intervention: Subjects on the waiting list for kidney transplant at VCUHS…. n = 38. 1 site: United States.

Key findings

Safety

Registry record contains no outcome data, safety results, or efficacy findings.

Who this may help

The source did not state who this applies to in practice.

Plain-language summary

This is a completed single-arm feasibility study with no reported results; it describes planned enrollment, interventions, and outcome measures without outcome data.

Study design

As stated by the source record.

MethodsPrimary outcome measures: Quality of Life-Lite survey (assessed at Only completed at baseline and week 40); Meal recall survey (assessed at completed at weeks 1, 4, 8, 12, 20 and 28); PrevenT2 education T (assessed at Weekly for weeks 1-12, then monthly on weeks 16, 24, 28, 32 and 36)

DesignInterventional, Single Group, Open label, Treatment purpose

PopulationKidney Transplant; Complications, Obesity; age from 18 Years

Sample size38

InterventionSubjects on the waiting list for kidney transplant at VCUHS…

Setting1 site: United States

Reported figures

Quoted from the source exactly as published.

Actual enrollment38

Primary outcome measure 1Quality of Life-Lite survey (baseline and week 40)

Primary outcome measure 2Meal recall survey (weeks 1, 4, 8, 12, 20, 28)

Primary outcome measure 3PrevenT2 education (weekly weeks 1–12, then monthly weeks 16, 24, 28, 32, 36)

Caveats

Registry record contains no outcome data, safety results, or efficacy findings.
Single-arm design without control group limits causal inference.
Study completion status noted but results not yet posted in this registry record.
No follow-up duration beyond week 40 reported.

Evidence assessment

Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.

Study design

limited

Single-arm feasibility design without control group or randomization.

Directness

moderate

Addresses obesity management pre-transplant; primary outcomes are quality of life and dietary recall.

Consistency

insufficient

Registry record only; no results reported for comparison with other studies.

Risk of bias

limited

No blinding, no control arm; feasibility study design inherently limited for outcome inference.

Sample adequacy

limited

Actual enrollment 38 participants; typical for feasibility studies but underpowered for efficacy.

What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.

Source abstract

Registry record from ClinicalTrials.gov (NCT06688825). This is a study registration, not published results. Lead sponsor: Virginia Commonwealth University. Recruitment status: COMPLETED. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 38 participants (ACTUAL). Conditions: Kidney Transplant; Complications, Obesity. Interventions: BEHAVIORAL: Education regarding Weight loss; BEHAVIORAL: Lifestyle tools for weight loss; BIOLOGICAL: Blood draw. Primary outcome measures: Quality of Life-Lite survey , Only completed at baseline and week 40; Meal recall survey , completed at weeks 1, 4, 8, 12, 20 and 28; PrevenT2 education T , Weekly for weeks 1-12, then monthly on weeks 16, 24, 28, 32 and 36. Brief summary: This project will be a single-arm feasibility study, with a treatment intervention that includes three interrelated components: (1) patient education using a proven weight loss curriculum, and (2) technology tools for making healthy lifestyle choices.

Follow from this

Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.

ObesityVirginia Commonwealth UniversityBlood drawLifestyle tools for weight lossKidney Transplant; ComplicationsNCT06688825Education regarding Weight loss